Literature DB >> 32636464

Can we cure refractory Hodgkin's lymphoma with transplantation?

Alina Tanase1,2, Anca Colita1,3, Stefan O Ciurea4,5, Piyanuch Kongtim6, Samer Srour7, Neeraj Saini7, Jin Im7, Jeremy Ramdial7, Issa Khouri7, Paolo Anderlini7, Uday Popat7, Chitra Hosing7, Richard E Champlin7, Hun J Lee8, Luis E Fayad8, Fredrick B Hagemeister8, Ana M Bica1, Lavinia Lipan1, Oana Craciun1, Cristina G Jercan1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32636464     DOI： 10.1038/s41409-020-0989-z

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  3 in total

1.  Haploidentical transplantation with post-infusion cyclophosphamide in advanced Hodgkin lymphoma.

Authors:  L Castagna; S Bramanti; R Devillier; B Sarina; R Crocchiolo; S Furst; J El-Cheikh; A Granata; C Faucher; S Harbi; L Morabito; J Mariotti; S Puvinathan; P J Weiller; C Chabannon; D Mokart; C Carlo-Stella; R Bouabdallah; A Santoro; D Blaise
Journal:  Bone Marrow Transplant       Date:  2017-05       Impact factor: 5.483

2.  Results of a 2-arm, phase 2 clinical trial using post-transplantation cyclophosphamide for the prevention of graft-versus-host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation.

Authors:  Sameh Gaballa; Isabell Ge; Riad El Fakih; Jonathan E Brammer; Piyanuch Kongtim; Ciprian Tomuleasa; Sa A Wang; Dean Lee; Demetrios Petropoulos; Kai Cao; Gabriela Rondon; Julianne Chen; Aimee Hammerstrom; Lindsey Lombardi; Gheath Alatrash; Martin Korbling; Betul Oran; Partow Kebriaei; Sairah Ahmed; Nina Shah; Katayoun Rezvani; David Marin; Qaiser Bashir; Amin Alousi; Yago Nieto; Muzaffar Qazilbash; Chitra Hosing; Uday Popat; Elizabeth J Shpall; Issa Khouri; Richard E Champlin; Stefan O Ciurea
Journal:  Cancer       Date:  2016-07-12       Impact factor: 6.860

3.  Reduced-intensity and non-myeloablative allogeneic stem cell transplantation from alternative HLA-mismatched donors for Hodgkin lymphoma: a study by the French Society of Bone Marrow Transplantation and Cellular Therapy.

Authors:  J Gauthier; L Castagna; F Garnier; T Guillaume; G Socié; S Maury; N Maillard; R Tabrizi; T Marchand; J Malfuson; A Gac; E Gyan; M Mercier; Y Béguin; J Delage; P Turlure; A Marçais; S Nguyen; R Dulery; J Bay; A Huynh; E Daguindau; J Cornillon; C Régny; M Michallet; R Peffault de Latour; I Yakoub-Agha; D Blaise
Journal:  Bone Marrow Transplant       Date:  2017-01-09       Impact factor: 5.483
  3 in total
  2 in total

Review 1.  Reappraising the Role of Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed and Refractory Hodgkin's Lymphoma: Recent Advances and Outcomes.

Authors:  Taha Al-Juhaishi; Azra Borogovac; Sami Ibrahimi; Matthew Wieduwilt; Sairah Ahmed
Journal:  J Pers Med       Date:  2022-01-18

Review 2.  Haploidentical Stem Cell Transplantation in Lymphomas-Expectations and Pitfalls.

Authors:  Jacopo Mariotti; Stefania Bramanti; Armando Santoro; Luca Castagna
Journal:  J Clin Med       Date:  2020-11-07       Impact factor: 4.241
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.